Trexquant Investment’s Cellectis CLLS Stock Holding History

Trexquant Investment’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-38,455	Closed	-$175K	–	1556
2022 Q1	$175K	Buy	38,455 +4,655	+14%	+$25.6K	0.01%	1226
2021 Q4	$274K	Buy	+33,800	New	+$332K	0.02%	975
2021 Q1	–	Sell	-8,857	Closed	-$240K	–	1155
2020 Q4	$240K	Buy	+8,857	New	+$199K	0.03%	808
2020 Q3	–	Sell	-14,081	Closed	-$251K	–	1226
2020 Q2	$251K	Sell	14,081 -5,510	-28%	-$83.9K	0.02%	965
2020 Q1	$180K	Buy	+19,591	New	+$292K	0.01%	988
2017 Q2	–	Sell	-8,919	Closed	-$214K	–	826
2017 Q1	$214K	Buy	+8,919	New	+$187K	0.03%	932
2016 Q2	–	Sell	-12,628	Closed	-$347K	–	897
2016 Q1	$347K	Sell	12,628 -4,263	-25%	-$103K	0.04%	690
2015 Q4	$524K	Buy	+16,891	New	+$513K	0.05%	662

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Trexquant Investment's CLLS Position: Q2 2022 in Review

Trexquant Investment sold out of Cellectis (CLLS) in Q2 2022, closing a stake of 38,455 shares — an estimated $175K sold.

Trexquant Investment first reported a position in CLLS in Q4 2015 and held it in 8 quarters. The position peaked at $524K in Q4 2015. 45 funds tracked by Wall St. Rank hold CLLS as of Q2 2022.

Trexquant Investment reported no remaining Cellectis position as of Q2 2022 after selling out during the quarter.
Trexquant Investment sold 38,455 Cellectis shares in Q2 2022, an estimated $175K.
Trexquant Investment first reported a position in Cellectis in Q4 2015 and held it in 8 quarters.
Trexquant Investment's Cellectis position peaked at $524K in Q4 2015.
45 funds tracked by Wall St. Rank held Cellectis as of Q2 2022.

Based on Trexquant Investment's 13F filing for Q2 2022, filed 11 Aug 2022.